Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CAMK family protein kinase | 0.0102 | 0.9845 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0068 | 0.5155 | 0.5155 |
Loa Loa (eye worm) | TAR-binding protein | 0.0068 | 0.5155 | 0.5236 |
Echinococcus granulosus | tar DNA binding protein | 0.0068 | 0.5155 | 0.5155 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0102 | 0.9845 | 0.5 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0102 | 0.9845 | 0.5 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0103 | 1 | 1 |
Giardia lamblia | Kinase, PLK | 0.0102 | 0.9845 | 1 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0038 | 0.0925 | 0.0925 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0102 | 0.9845 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0054 | 0.312 | 0.312 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.5155 | 0.5236 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0038 | 0.0925 | 0.0939 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0102 | 0.9845 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0038 | 0.0925 | 0.0939 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0054 | 0.312 | 0.3169 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0102 | 0.9845 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0038 | 0.0925 | 0.0925 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0038 | 0.0925 | 0.0925 |
Brugia malayi | RNA binding protein | 0.0068 | 0.5155 | 0.5155 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0102 | 0.9845 | 0.5 |
Echinococcus granulosus | jumonji domain containing protein | 0.0044 | 0.1721 | 0.1721 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.5155 | 0.5236 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0102 | 0.9845 | 0.9845 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0038 | 0.0925 | 0.0939 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0742 | 0.0754 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0102 | 0.9845 | 0.9845 |
Brugia malayi | TAR-binding protein | 0.0068 | 0.5155 | 0.5155 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0102 | 0.9845 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0068 | 0.5155 | 0.5236 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.314 | 0.3189 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0102 | 0.9845 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.0102 | 0.9845 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.312 | 0.3169 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0103 | 1 | 1 |
Plasmodium falciparum | phd finger protein, putative | 0.0032 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0102 | 0.9845 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.5155 | 0.5236 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0032 | 0 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0054 | 0.312 | 0.312 |
Schistosoma mansoni | jumonji domain containing protein | 0.0082 | 0.7041 | 0.7152 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0742 | 0.0754 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0102 | 0.9845 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0102 | 0.9845 | 0.9845 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.5155 | 0.5236 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0032 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0102 | 0.9845 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0032 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.5155 | 0.5236 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0102 | 0.9845 | 1 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0044 | 0.1721 | 0.1721 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0068 | 0.5155 | 0.5236 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0102 | 0.9845 | 1 |
Schistosoma mansoni | kinase | 0.0052 | 0.2842 | 0.2887 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.0742 | 0.0742 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0068 | 0.5155 | 0.5155 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0065 | 0.468 | 0.4754 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (ADMET) | = 0.8 uM | Inhibition of CYP3A4 uisng testosterone substrate | ChEMBL. | 21666860 |
IC50 (ADMET) | = 1.4 uM | Inhibition of CYP2D6 | ChEMBL. | 21666860 |
IC50 (ADMET) | = 4.3 uM | Inhibition of CYP3A4 uisng midazolam substrate | ChEMBL. | 21666860 |
Ratio (binding) | = 15100 /M/s | Irreversible inhibition of His-tagged rat FAAH N-terminal transmembrane-deleted truncated form expressed in Escherichia coli assessed as ratio of Kinact to Ki by GDH-coupled FAAH assay | ChEMBL. | 21666860 |
Ratio (binding) | = 21600 /M/s | Irreversible inhibition of His-tagged human FAAH N-terminal transmembrane-deleted truncated form expressed in Escherichia coli assessed as ratio of Kinact to Ki by GDH-coupled FAAH assay | ChEMBL. | 21666860 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.